Pain Management News and Research

RSS

Acura, Pfizer receive FDA approval for OXECTA Tablets to manage severe pain

Pfizer Inc. and Acura Pharmaceuticals Inc. announce the marketing approval from the U.S. Food and Drug Administration (FDA) of OXECTATM Tablets CII.

20 Jun 2011

Enrollment complete in NeurogesX NGX-1998 Phase 2 clinical study for postherpetic neuralgia

NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced the completion of patient enrollment in its Phase 2 clinical study of NGX-1998, a topical liquid formulation of high-concentration capsaicin, in patients with postherpetic neuralgia (PHN).

16 Jun 2011

Bio-Nucleonics resumes production of metastatic cancer drug, Strontium-89

Bio-Nucleonics, Inc., a life sciences Company, specializing in the development and manufacture of radiopharmaceuticals, medical devices and imaging agents, will be attending the Society of Nuclear Medicine (SNM) Annual Meeting, held in San Antonio, TX, June 4th through 8th, 2011.

8 Jun 2011

Enrollment complete in Adolor's ADL5945 Phase 2 clinical study in opioid-induced constipation

Adolor Corporation today announced that it has completed enrollment in its Phase 2 clinical evaluation of ADL5945 in chronic, non-cancer pain patients with opioid-induced constipation (OIC).

6 Jun 2011

Hartford Faculty Scholars Program grants two-year award to geriatric social work researchers

The prestigious Hartford Faculty Scholars Program has granted 11 geriatric social work researchers a two-year award that will provide career development, mentorship, and support for projects that will improve healthy outcomes for the country's aging population.

4 Jun 2011

Physiotherapy Associates inaugurates new Cedar Park facility

Physiotherapy Associates, the nation's foremost provider of outpatient rehabilitation services, recently opened a new physical therapy clinic in Cedar Park, TX. The Strickland Physical Therapy Associates clinic offers a comprehensive range of physical therapy services, including: manual therapy, foot and ankle, neck and back, and sports medicine.

4 Jun 2011

Nerve stimulation device approved for pain

The Medtronic Inc. has won the CE Mark approval for a peripheral nerve stimulation device for treating chronic back pain. This medical device maker from Minneapolis, Minn. said the implantable device will fit into its neurostimulation business, which operates out of the company's restorative therapies division. That unit was responsible for about $5.42 billion in sales during the nine-month period ended Jan. 28.

From Medtronic 24 May 2011

Millennium Laboratories founder to be honored as 2011 Ernst & Young Entrepreneur for pain care

Millennium Laboratories, a leading provider of medication monitoring services to physicians and staff treating chronic pain, announced today that James Slattery, CEO and founder, is a regional finalist for the Ernst & Young Entrepreneur of the Year 2011 San Diego region.

23 May 2011

NIH allocated $400 million funding for pain research in 2010

An unprecedented level of federal funding for pain research, some $400 million, was allocated in 2010 by the National Institutes of Health (NIH) through provisions of the American Recovery and Investment Act and the Affordable Care Act to help accelerate advances in pain research, prevention and treatment.

21 May 2011

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

The American Pain Society, www.ampainsoc.org, today honored the recipients of its fifth annual Clinical Centers of Excellence in Pain Management Awards recognizing the nation's outstanding pain care centers.

21 May 2011

Complementary and alternative health practices show promise for management of pain

A variety of complementary and alternative health practices —including meditation and relaxation techniques, manual therapies such as massage and spinal manipulation, meditative exercise forms such as yoga, Tai Chi, and ancient health practices such as acupuncture—show promise for contributing to the management of pain according to research presented at the Annual Scientific Meeting of the American Pain Society, www.ampainsoc.org.

20 May 2011

Online program helps people to manage chronic pain

There is good news for the 76 million Americans who experience chronic pain including migraine, back pain, fibromyalgia and arthritis. A new study reveals that an online, self-paced chronic pain management program reduces the physical and psychological burdens of this debilitating condition.

19 May 2011

Treatment of chronic low back pain can reverse abnormal brain activity and function

It likely comes as no surprise that low back pain is the most common form of chronic pain among adults. Lesser known is the fact that those withchronic pain also experience cognitive impairments and reduced gray matter in parts of the brain associated with pain processing and the emotional components of pain, like depression and anxiety.

18 May 2011

iPads help minimize children's pain during procedures

Nurses in the emergency department at NewYork-Presbyterian/Morgan Stanley Children's Hospital are pioneering techniques -- including the use of iPads -- to improve the patient experience by eliminating or minimizing pain.

7 May 2011

Pacira to present EXPAREL data in postsurgical pain at two medical meetings

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced that clinical and preclinical data highlighting the safety and efficacy of EXPAREL™ will be presented at two medical meetings.

6 May 2011

Hebei Aoxing Pharma receives Chinese patent for naloxone sublingual film

Aoxing Pharmaceutical, a specialty pharmaceutical company focusing on research, development, manufacturing and distribution of narcotic and pain-management products, announced that its operating subsidiary in China, Hebei Aoxing Pharmaceutical Group Company, has been granted a patent by the State Intellectual Property Office of The People's Republic of China for naloxone sublingual film.

3 May 2011

Teva signs definitive agreement to acquire Cephalon shares for $6.8 billion

Teva Pharmaceutical Industries Ltd. and Cephalon, Inc. today announced that their Boards of Directors have unanimously approved a definitive agreement under which Teva will acquire all of the outstanding shares of Cephalon for $81.50 per share in cash, or a total enterprise value of approximately $6.8 billion. The transaction is not conditioned on financing and is expected to be completed in the third quarter of 2011.

2 May 2011

LSI announces publication of Emerging Medtech Companies report

Life Science Intelligence, a leading medical technology market intelligence firm, has announced the publication of its Report on Emerging Medtech Companies in Q1 2011.

30 Apr 2011

AACN to recognize Janet Marvin with Marguerite Rodgers Kinney Award for a Distinguished Career

The American Association of Critical-Care Nurses will present the Marguerite Rodgers Kinney Award for a Distinguished Career to Janet Marvin, RN, MN. She receives this Visionary Leadership Award for contributions to AACN's mission and vision at the 2011 National Teaching Institute & Critical Care Exposition, Chicago, April 30-May 5.

30 Apr 2011

NeurogesX first quarter revenue is $3.2 million for 2011

NeurogesX, Inc., a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today reported results for its first quarter ended March 31, 2011.

30 Apr 2011

Pain Management News and Research

Acura, Pfizer receive FDA approval for OXECTA Tablets to manage severe pain

Enrollment complete in NeurogesX NGX-1998 Phase 2 clinical study for postherpetic neuralgia

Bio-Nucleonics resumes production of metastatic cancer drug, Strontium-89

Enrollment complete in Adolor's ADL5945 Phase 2 clinical study in opioid-induced constipation

Hartford Faculty Scholars Program grants two-year award to geriatric social work researchers

Physiotherapy Associates inaugurates new Cedar Park facility

Nerve stimulation device approved for pain

Millennium Laboratories founder to be honored as 2011 Ernst & Young Entrepreneur for pain care

NIH allocated $400 million funding for pain research in 2010

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

Complementary and alternative health practices show promise for management of pain

Online program helps people to manage chronic pain

Treatment of chronic low back pain can reverse abnormal brain activity and function

iPads help minimize children's pain during procedures

Pacira to present EXPAREL data in postsurgical pain at two medical meetings

Hebei Aoxing Pharma receives Chinese patent for naloxone sublingual film

Teva signs definitive agreement to acquire Cephalon shares for $6.8 billion

LSI announces publication of Emerging Medtech Companies report

AACN to recognize Janet Marvin with Marguerite Rodgers Kinney Award for a Distinguished Career

NeurogesX first quarter revenue is $3.2 million for 2011

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News